Complete Filing Data
BioLineRx Ltd. reported Cash And Cash Equivalents of $3.25 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BioLineRx Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $3.1M | $6.3M | $6.3M | $5.1M | $4.3M | $3.9M | $3.8M | $4.4M | $4.0M | $4.0M | $3.7M |
| Sales And Marketing Expense | $0.00 | $23.6M | $25.3M | $6.5M | $1.0M | $840.0K | $857.0K | $1.4M | $1.7M | $1.4M | $1.0M |
| Research And Development Expense | $8.1M | $9.1M | $12.5M | $17.6M | $19.5M | $18.2M | $23.4M | $19.8M | $19.5M | $11.2M | $11.5M |
| Profit Loss From Operating Activities | -$10.3M | -$20.4M | -$49.7M | -$29.2M | -$24.8M | -$22.9M | -$28.1M | -$25.6M | -$25.2M | -$16.5M | -$16.2M |
| Profit Loss From Non Operating Activities | $8.1M | $18.4M | -$10.8M | $5.7M | -$1.8M | -$5.7M | $4.2M | $2.4M | -$260.0K | $214.0K | $1.4M |
| Profit Loss | -$2.0M | -$9.2M | -$60.6M | -$25.0M | -$27.1M | -$30.0M | -$25.4M | -$23.0M | -$24.4M | -$15.8M | -$14.4M |
| Adjustments For Reconcile Profit Loss | -$6.0M | -$34.7M | $38.0M | -$1.3M | $3.5M | $6.8M | $2.8M | -$1.2M | $3.8M | $1.3M | $232.0K |
| Gross Profit | $950.0K | $19.7M | $1.1M | $0.00 | $0.00 | ||||||
| Cost Of Sales | $230.0K | $9.3M | $3.7M | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $3.3M | $10.4M | $4.3M | $10.6M | $13.0M | $16.8M | $5.3M | $3.4M | $5.1M | $2.5M | $5.5M | $5.8M |
| Total Income And Expense Not Involving Cash Flows | -$7.3M | -$12.8M | $22.8M | -$2.5M | $4.0M | $8.1M | -$1.5M | $477.0K | $1.2M | $917.0K | $78.0K | |
| Total Change In Operating Asset And Liability | $1.3M | -$21.8M | $15.2M | $1.2M | -$540.0K | -$1.3M | $4.3M | -$1.7M | $2.6M | $411.0K | $154.0K | |
| Cash Flows From Used In Operating Activities | -$8.1M | -$43.9M | -$22.6M | -$26.2M | -$23.6M | -$23.2M | -$22.7M | -$24.2M | -$20.5M | -$14.5M | -$14.2M | |
| Cash Flows From Used In Investing Activities | -$8.5M | $29.4M | $1.4M | $4.0M | -$38.2M | $16.7M | $5.3M | $9.6M | -$15.9M | $9.3M | -$15.6M | |
| Cash Flows From Used In Financing Activities | $8.9M | $20.7M | $15.1M | $20.4M | $57.7M | $17.9M | $19.2M | $13.1M | $38.7M | $2.1M | $29.5M | |
| Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments | -$36.6M | -$26.4M | -$47.6M | -$44.0M | -$78.0M | -$33.5M | -$43.5M | -$26.5M | -$44.0M | -$33.0M | -$63.1M | |
| Adjustments For Increase Decrease In Trade Account Payable | -$3.5M | -$5.5M | $5.5M | $1.9M | -$564.0K | -$1.7M | $3.2M | -$773.0K | $3.1M | $369.0K | $196.0K | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $25.0K | $53.0K | $116.0K | $131.0K | $97.0K | $0.00 | $67.0K | $173.0K | $338.0K | $52.0K | $2.7M | |
| Adjustments For Decrease Increase In Prepaid Expenses And Other Operating Receivables | -$1.3M | $43.0K | $959.0K | $650.0K | -$24.0K | -$428.0K | -$1.1M | $934.0K | $415.0K | -$42.0K | $42.0K | |
| Issue Of Equity | $5.5M | $8.3M | $14.1M | $5.5M | $50.4M | $14.2M | $15.7M | $8.8M | $40.7M | $2.2M | $29.1M | |
| Supplemental Information On Interest Paid In Cash | $1.3M | $10.4M | $1.1M | $593.0K | $682.0K | $994.0K | $1.2M | $165.0K | $12.0K | |||
| Trade And Other Current Payables To Trade Suppliers | $3.5M | $5.6M | $10.9M | $7.0M | $5.6M | $5.9M | $7.8M | $4.5M | $5.5M | $2.6M | ||
| Shortterm Investments Classified As Cash Equivalents | $17.6M | $9.1M | $38.7M | $40.5M | $44.1M | $5.8M | $22.2M | $26.7M | $44.4M | $33.2M | ||
| Retained Earnings | -$401.0M | -$399.8M | -$390.6M | -$330.0M | -$305.0M | -$278.0M | -$248.0M | -$222.5M | -$199.6M | -$175.2M | ||
| Purchase Of Intangible Assets Classified As Investing Activities | $2.0K | $1.0K | $181.0K | $185.0K | $0.00 | $0.00 | $6.0K | $10.0M | $3.9M | $3.0K | $36.0K | |
| Property Plant And Equipment | $160.0K | $386.0K | $473.0K | $726.0K | $952.0K | $1.3M | $1.8M | $2.2M | $2.5M | $2.6M | ||
| Other Current Receivables | $410.0K | $1.5M | $830.0K | $721.0K | $142.0K | $141.0K | $613.0K | $1.3M | $586.0K | $223.0K | ||
| Other Current Payables | $1.7M | $3.1M | $3.4M | $1.7M | $1.2M | $1.4M | $1.3M | $1.4M | $1.1M | $978.0K | ||
| Noncurrent Liabilities | $5.4M | $10.0M | $7.9M | $14.9M | $3.6M | $14.6M | $8.2M | $8.2M | $1.4M | $251.0K | ||
| Noncurrent Assets | $17.2M | $11.8M | $16.7M | $24.4M | $24.0M | $24.4M | $25.4M | $24.3M | $10.6M | $2.8M | ||
| Liabilities | $17.6M | $25.4M | $50.7M | $25.5M | $13.3M | $25.3M | $20.2M | $14.9M | $8.1M | $3.9M | ||
| Intangible Assets Other Than Goodwill | $16.4M | $10.4M | $14.9M | $21.9M | $21.7M | $21.7M | $21.9M | $22.0M | $7.0M | $181.0K | ||
| Equity And Liabilities | $40.9M | $38.9M | $63.9M | $76.4M | $81.4M | $47.3M | $53.6M | $56.2M | $61.0M | $38.9M | ||
| Current Liabilities | $12.1M | $15.4M | $42.8M | $10.7M | $9.7M | $10.6M | $12.0M | $6.8M | $6.7M | $3.7M | ||
| Current Assets | $23.7M | $27.1M | $47.2M | $52.0M | $57.4M | $22.9M | $28.2M | $32.0M | $50.4M | $36.1M | ||
| Assets | $40.9M | $38.9M | $63.9M | $76.4M | $81.4M | $47.3M | $53.6M | $56.2M | $61.0M | $38.9M | ||
| Accumulated Other Comprehensive Income | -$1.4M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | ||
| Supplementary Information On Interest Received In Cash | $1.2M | $2.0M | $2.0M | $342.0K | $138.0K | $381.0K | $868.0K | $834.0K | $494.0K | $453.0K | $173.0K | |
| Exchange Differences On Lease Liability | $177.0K | -$31.0K | -$42.0K | -$224.0K | $55.0K | $125.0K | $154.0K | |||||
| Rightofuse Assets | $696.0K | $967.0K | $1.4M | $1.8M | $1.3M | $1.4M | $1.7M | |||||
| Noncurrent Lease Liabilities | $977.0K | $1.1M | $1.3M | $1.7M | $1.7M | $1.7M | $1.8M | |||||
| Current Lease Liabilities | $234.0K | $522.0K | $528.0K | $427.0K | $168.0K | $191.0K | $202.0K | |||||
| Adjustments For Increase Decrease In Contract Liabilities | $0.00 | -$13.0M | $13.0M | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Issuing Shares | 13.9M | 16.4M | 14.1M | 14.4M | 50.4M | 19.2M | 20.3M | 3.8M | 38.8M | 2.2M | 29.1M |
| Increase Decrease In Cash And Cash Equivalents | -$7.7M | $6.2M | -$6.1M | -$1.8M | -$4.0M | $11.3M | $1.8M | -$1.5M | $2.2M | -$3.1M | -$279.0K |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $549.0K | $22.0K | -$224.0K | -$607.0K | $207.0K | $206.0K | $108.0K | -$166.0K | $435.0K | $51.0K | $33.0K |
| Payments Of Lease Liabilities Classified As Financing Activities | $512.0K | $511.0K | $445.0K | $220.0K | $196.0K | $224.0K | $215.0K | ||||
| Proceeds From Issuing Other Equity Instruments | $0.00 | $19.2M | $0.00 | $9.1M | $0.00 | $0.00 | $9.6M | ||||
| Proceeds From Exercise Of Warrants | $0.00 | $0.00 | $2.9M | $0.00 | $10.9M | $2.0M | $0.00 | ||||
| Proceeds From Exercise Of Options | $0.00 | $22.0K | $27.0K | $5.0K | $7.0K | $8.0K | $1.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Shares | 2.47B | 1.20B | 963.4M | 774.0M | 662.9M | 252.8M | 146.4M | 108.6M | 90.0M | 56.1M | 51.4M |
| Diluted Earnings Loss Per Share | $0.00 | $-0.01 | $-0.06 | $-0.03 | $-0.04 | $-0.12 | |||||
| Basic Earnings Loss Per Share | $0.00 | $-0.01 | $-0.06 | $-0.03 | $-0.04 | $-0.12 | |||||
| Basic And Diluted Earnings Loss Per Share | $-0.04 | $-0.12 | $-0.17 | $-0.21 | $-0.27 | $-0.28 | $-0.28 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Finance Income | $1.5M | $1.9M | $2.1M | $694.0K | $559.0K | $236.0K | $777.0K | $719.0K | $1.2M | $480.0K | $457.0K |
| Finance Costs | $1.3M | $9.1M | $2.2M | $2.2M | $1.0M | $1.6M | $2.3M | $473.0K | $21.0K | $22.0K | $106.0K |
| Increase Decrease Through Sharebased Payment Transactions | $396.0K | $1.1M | $2.3M | $2.2M | $1.5M | $1.3M | $1.8M | $2.5M | $1.5M | $1.1M | $1.2M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$549.0K | -$22.0K | $224.0K | $607.0K | -$207.0K | -$206.0K | -$108.0K | $166.0K | -$435.0K | -$51.0K | -$33.0K |
| Adjustments For Sharebased Payments | $396.0K | $1.1M | $2.3M | $2.2M | $1.5M | $1.3M | $1.8M | $2.5M | $1.5M | $1.1M | $1.2M |
| Adjustments For Depreciation And Amortisation Expense | $523.0K | $4.1M | $1.4M | $654.0K | $703.0K | $934.0K | $940.0K | $545.0K | $481.0K | $482.0K | $441.0K |
| Adjustments For Fair Value Gains Losses | -$8.6M | -$19.0M | $11.1M | -$6.4M | $1.9M | $5.1M | -$4.6M | -$1.7M | $127.0K | -$207.0K | -$1.3M |
| Warrants | $2.2M | $1.7M | $11.9M | $4.5M | $1.9M | $10.2M | $658.0K | $323.0K | $1.2M | $1.0K | |
| Share Premium | $327.6M | $353.7M | $355.5M | $339.0M | $339.3M | $279.2M | $265.9M | $250.2M | $240.7M | $199.6M | |
| Issued Capital | $73.4M | $38.1M | $31.4M | $27.1M | $21.1M | $9.9M | $4.7M | $3.1M | $2.8M | $1.5M | |
| Increase Decrease Through Exercise Of Options | $22.0K | $27.0K | $5.0K | $7.0K | $8.0K | $1.0K | -$46.0K | ||||
| Current Prepaid Expenses | $201.0K | $443.0K | $1.0M | $198.0K | $127.0K | $152.0K | $108.0K | $488.0K | $307.0K | $255.0K | |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | $4.5M | $4.5M | $3.1M | $1.5M | $2.8M | $3.1M | $2.7M | $895.0K | $93.0K | $93.0K | |
| Capital Reserve | $15.9M | $17.5M | $17.0M | $14.8M | $13.2M | $12.3M | $12.1M | $12.0M | $10.3M | $10.6M | |
| Noncurrent Portion Of Noncurrent Loans Received | $4.5M | $9.0M | $6.6M | $8.6M | $0.00 | $2.7M | $5.8M | $7.8M | $157.0K | $250.0K | |
| Interest And Exchange Differences On Restricted Deposits | $702.0K | $669.0K | $0.00 | $171.0K | $0.00 | $594.0K | $417.0K | $17.0K | |||
| Maturities Of Short Term Deposits | -$28.1M | -$55.8M | -$49.3M | -$48.3M | -$39.9M | -$50.2M | -$48.9M | ||||
| Interest And Linkage Differences On Bank Loan | $0.00 | -$1.1M | $1.1M | $1.1M | $301.0K | $474.0K | $647.0K | $123.0K | -$1.0K | $1.0K | |
| Interest And Exchange Differences On Short Term Deposits | $18.0K | $185.0K | $15.0K | -$672.0K | -$262.0K | -$232.0K | -$775.0K | ||||
| Increase Decrease Through Forfeited And Expired Of Options | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Repayments Of Current Borrowings | $93.0K | $93.0K | $93.0K | $31.0K | |||||||
| Maturities Of Shortterm Deposits | -$28.1M | -$55.8M | -$49.3M | -$48.3M | -$39.9M | -$50.2M | -$48.9M | ||||
| Interest And Exchange Differences On Shortterm Deposits | $18.0K | $185.0K | $15.0K | -$672.0K | -$262.0K | -$232.0K | -$775.0K | ||||
| Longterm Prepaid Expenses | $56.0K | $5.0K | -$9.0K | $6.0K | -$9.0K |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.